Related references
Note: Only part of the references are listed.Lipid and Nucleic Acid Chemistries: Combining the Best of Both Worlds to Construct Advanced Biomaterials
Julie Baillet et al.
ADVANCED MATERIALS (2018)
Chemotherapeutic agents for the treatment of metastatic breast cancer: An update
Mariam Abotaleb et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development
Samuel M. Meier-Menches et al.
CHEMICAL SOCIETY REVIEWS (2018)
Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents
Mousumi Pal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Mechanism and medical implications of mammalian autophagy
Ivan Dikic et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy
Mija Marinkovic et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
AS1411-decorated niosomes as effective nanocarriers for Ru(III)-based drugs in anticancer strategies
Claudia Riccardi et al.
JOURNAL OF MATERIALS CHEMISTRY B (2018)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets
Jerry M. Adams et al.
CELL DEATH AND DIFFERENTIATION (2018)
Autophagy-from molecular mechanisms to clinical relevance
Monika Lippai et al.
CELL BIOLOGY AND TOXICOLOGY (2017)
A ruthenium anticancer compound interacts with histones and impacts differently on epigenetic and death pathways compared to cisplatin
Cynthia Licona et al.
ONCOTARGET (2017)
Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
Prakash Thangavel et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Enhanced Antimetastatic Activity of the Ruthenium Anticancer Drug RAPTA-C Delivered in Fructose-Coated Micelles
Mingxia Lu et al.
MACROMOLECULAR BIOSCIENCE (2017)
A Review of Ruthenium Complexes Activities on Breast Cancer Cells
Cecilia P. Popolin et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
Metal complexes in cancer therapy - an update from drug design perspective
Umar Ndagi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)
Upendarrao Golla et al.
ONCOTARGET (2017)
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action
Carlo Irace et al.
SCIENTIFIC REPORTS (2017)
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Xiaofeng Dai et al.
JOURNAL OF CANCER (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials
Leli Zeng et al.
CHEMICAL SOCIETY REVIEWS (2017)
Awareness and current knowledge of breast cancer
Muhammad Akram et al.
BIOLOGICAL RESEARCH (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Supramolecular Delivery Systems for NonPlatinum Metal-Based Anticancer Drugs
Paola Ringhieri et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2017)
Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies
Giulia Palermo et al.
CHEMMEDCHEM (2016)
The potential of Beclin 1 as a therapeutic target for the treatment of breast cancer
Yoon Yang Jung et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Anticancer effect of rapamycin on MCF-7 via downregulation of VEGF expression
Takaaki Fujii et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2016)
Autophagy induction for the treatment of cancer
Federico Pietrocola et al.
AUTOPHAGY (2016)
Current challenges of metastatic breast cancer
Bora Lim et al.
CANCER AND METASTASIS REVIEWS (2016)
Recent Trends in Nucleotide Synthesis
Beatrice Roy et al.
CHEMICAL REVIEWS (2016)
Mechanisms of Selective Autophagy in Normal Physiology and Cancer
Joseph D. Mancias et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target
Flavia Radogna et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Recent insights into cell death and autophagy
Brent E. Fitzwalter et al.
FEBS JOURNAL (2015)
Ruthenium complex Lambda-WH0402 induces hepatocellular carcinoma LM6 (HCCLM6) cell death by triggering the Beclin-1-dependent autophagy pathway
Jian Yuan et al.
METALLOMICS (2015)
Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex
Giuseppe Vitiello et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Suzanne Leijen et al.
INVESTIGATIONAL NEW DRUGS (2015)
Autophagy, cell death, and cancer
Lin Lin et al.
MOLECULAR & CELLULAR ONCOLOGY (2015)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
The Importance of Autophagy Regulation in Breast Cancer Development and Treatment
Joanna Magdalena Zarzynska
BIOMED RESEARCH INTERNATIONAL (2014)
Anticancer Cationic Ruthenium Nanovectors: From Rational Molecular Design to Cellular Uptake and Bioactivity
Gaetano Mangiapia et al.
BIOMACROMOLECULES (2013)
A new design for nucleolipid-based Ru(III) complexes as anticancer agents
Daniela Montesarchio et al.
DALTON TRANSACTIONS (2013)
Beclin-1: Autophagic regulator and therapeutic target in cancer
Lei-lei Fu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Cholesterol-Based Nucleolipid-Ruthenium Complex Stabilized by Lipid Aggregates for Antineoplastic Therapy
Luca Simeone et al.
BIOCONJUGATE CHEMISTRY (2012)
Ruthenium-based complex nanocarriers for cancer therapy
Gaetano Mangiapia et al.
BIOMATERIALS (2012)
2,3,7,8-Tetrachlorodibenzo-p-dioxin impairs iron homeostasis by modulating iron-related proteins expression and increasing the labile iron pool in mammalian cells
Rita Santamaria et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Autophagy: Renovation of Cells and Tissues
Noboru Mizushima et al.
CELL (2011)
Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis
Feifan Zhou et al.
FEBS JOURNAL (2011)
Nucleolipid nanovectors as molecular carriers for potential applications in drug delivery
Luca Simeone et al.
MOLECULAR BIOSYSTEMS (2011)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
Design, Synthesis and Characterisation of a Fluorescently Labelled CyPLOS Ionophore
Cinzia Coppola et al.
CHEMISTRY-A EUROPEAN JOURNAL (2010)
BREAST CANCER: Challenges, controversies, breakthroughs
Lisa Hutchinson
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
Frederike Lentz et al.
ANTI-CANCER DRUGS (2009)
W7FW14F Apomyoglobin Amyloid Aggregates-Mediated Apoptosis Is Due to Oxidative Stress and AKT Inactivation Caused by Ras and Rac
Ivana Sirangelo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
Oxalomalate affects the inducible nitric oxide synthase expression and activity
Carlo Irace et al.
LIFE SCIENCES (2007)
Induction of H-ferritin synthesis by oxalomalate is regulated at both the transcriptional and post-transcriptional levels
Rita Santamaria et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
Nucleolipids: Natural occurrence, synthesis, molecular recognition, and supramolecular assemblies as potential precursors of life and bioorganic materials
H Rosemeyer
CHEMISTRY & BIODIVERSITY (2005)
Autophagy as a cell death and tumor suppressor mechanism
D Gozuacik et al.
ONCOGENE (2004)
Share Paper
